Evaluation of the Efficacy and Safety of Clazosentan in Reversing Cerebral Vasospasm in Adult Subjects With Aneurysmal Subarachnoid Hemorrhage
Clinical trial NCT02560532 · COMPLETED
Trial details
- NCT number
- NCT02560532
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2017-05-02
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.